News & Events
Becton Dickinson Biosciences Leukemia and Lymphoma Product Development Team Volunteers Time at Leukemia Society of America's Cure-a-Thon
|
Contact: Mark Herberger, BD Biosciences Immunocytometry Systems (408) 954-2211 San Jose, CA (March 15, 1999) -- Becton Dickinson Biosciences, a division of Becton Dickinson and Company, today announced that a core team of company associates volunteered to take telephone calls for the Leukemia Society of America’s Cure-a-Thon held March 12th and 13th at KGO Radio in San Francisco. The Becton Dickinson Biosciences team is responsible for a new leukemia and lymphoma system that, when completed, will provide reagent and software solutions to increase productivity and the quality of results for pathologists and laboratorians who analyze leukemia and lymphoma samples. Leukemia and lymphoma are cancers of the blood that originate in the bone marrow and lymphatic tissues. Normal cells undergo a malignant change that causes them to multiply and crowd out the healthy cells. An estimated 100,000 people in the US will be diagnosed with leukemia and lymphoma in 1999. These cancers will kill an estimated 60,000 persons in the US this year.
Becton Dickinson and Company manufactures and sells a broad range of medical supplies and devices and diagnostic systems for use by health care professionals, medical research institutions, industry and the general public. In 1973, Becton Dickinson Biosciences pioneered the development of the first cell sorter, FACS®. Since then, BDB has become the worldwide leader in flow cytometry systems for both the clinical and research markets. Included in the BDB product line are highly sophisticated flow cytometers and cell sorters, advanced application and data management software, and a wide range of reagents that allow users to analyze, isolate, and characterize cells from blood and tissue.
|